Rockefeller Capital Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
Rockefeller Capital Management's CLB Position: Q2 2026 in Review
Rockefeller Capital Management held its Core Laboratories (CLB) position steady in Q2 2026 at 201 shares worth $2.35K. The position accounts for ﹤0.01% of the portfolio, ranked #4396.
Rockefeller Capital Management first reported a position in CLB in Q1 2019 and has held it in 20 quarters since. The position peaked at $84K in Q2 2021. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Rockefeller Capital Management held 201 shares of Core Laboratories worth $2.35K as of Q2 2026.
- Rockefeller Capital Management left its Core Laboratories share count unchanged in Q2 2026.
- Core Laboratories made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4396 holding.
- Rockefeller Capital Management first reported a position in Core Laboratories in Q1 2019 and has held it in 20 quarters since.
- Rockefeller Capital Management's Core Laboratories position peaked at $84K in Q2 2021.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.